Experimental evidence for a pathogenic role of anti-pla2r1 antibodies in membranous nephropathy


Experimental evidence for a pathogenic role of anti-pla2r1 antibodies in membranous nephropathy

Play all audios:


Access through your institution Buy or subscribe Circulating anti-phospholipase A2 receptor 1 (anti-PLA2R1) antibodies are found in 70–80% of patients with membranous nephropathy. A new


study provides experimental evidence of the pathogenicity of these antibodies in this disease. The researchers conclude that human anti-PLA2R1 antibodies have a pathogenic role in membranous


nephropathy. However, they comment that their data do not exclude the possibility that other factors in the plasma of patients may also contribute to the development of the disease. This is


a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our


best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue


Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL


ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES ORIGINAL ARTICLE * Reinhard, L. et al. Pathogenicity of human


anti-PLA2R1 antibodies in minipigs: a pilot study. _J. Am. Soc. Nephrol._ https://doi.org/10.1681/ASN.0000000000000068 (2023) Article  PubMed  Google Scholar  Download references AUTHOR


INFORMATION AUTHORS AND AFFILIATIONS * Nature Reviews Nephrology http://www.nature.com/nrneph Ellen F. Carney Authors * Ellen F. Carney View author publications You can also search for this


author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Ellen F. Carney. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Carney, E.F.


Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy. _Nat Rev Nephrol_ 19, 213 (2023). https://doi.org/10.1038/s41581-023-00697-x Download


citation * Published: 27 February 2023 * Issue Date: April 2023 * DOI: https://doi.org/10.1038/s41581-023-00697-x SHARE THIS ARTICLE Anyone you share the following link with will be able to


read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing


initiative